Luxembourg, 9th August 2020: Flen Health expresses its solidarity to Lebanon by donating Flaminal® Hydro and Flaminal® Forte in the value of 270.000 € to help thousands of injured people after two explosions hit the city of Beirut on 4th August 2020. As several hospitals have been destroyed or are only half operational, numerous healthcare professionals in operational medical facilities face the challenge of taking efficient care of the many injured and also having to deal with the effects of COVID-19. “As a company specialized in wound healing, we want to help and contribute to better patient care where needed. Flaminal® can be used by healthcare professionals as well as patients to quickly and efficiently treat severe wounds caused by the explosions”, says Simon Eaves, International Business Developer at Flen Health. Now, that the donation is approved by the Ministry of Health (MOH) in Beirut, Flen Health is able to ship the needed goods via air transport from Luxembourg directly to the MOH. Subsequently, the wound healing ointment can be distributed to all government hospitals. Flen Health’s local contact will be able to be in touch with the healthcare professionals in Lebanon to provide on the ground support. “The donation will go to governmental hospitals in all Lebanon. Due to the catastrophe in Beirut and lots of injuries and burn cases hospitals are in need of medical donations. No one knows how the current situation evolves but with the help we receive we can clearly move one step forward and improve wound care where needed the most”, explains Ola Hajjeh, Pharmacist at Hajjeh Pharmacy in Lebanon. About Flen Health Flen Health believes biotech innovations can help to build a securer life for all of us. With its product portfolio, Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin diseases in a responsible way. Furthermore, provide added value to patients, healthcare professionals and health authorities. Learn more about Flen Health
Esch-sur-Alzette, 30th July 2020: Together with the Minister of Economy, Franz Fayot, Flen Health’s CEO, Philippe Sollie and Flen Health’s VP R&D, Gilles Brackman reflected on how the BioHealth sector in Luxembourg has developed over the previous years and what role Flen Health has played and will play towards Luxembourg’s BioHealth. Since 2011 Flen Health’s headquarters have been located in Luxembourg. In 2017 the medical device and biotechnology company secured an important R&D fund provided by the Ministry of Economy of the Grand Duchy of Luxembourg and an additional loan supplied by the EFSI. Flen Health was able to grow its R&D work force and also able to work on several R&D projects that supported the development of innovative biotechnologies. “Flen Health is grateful for the financial aid it receives from government bodies and commits to use that aid responsibly to realise its mission. Our mission is clear and hasn`t changed since I founded the company in 2000. Flen Health develops innovation that helps people around the world, with infectious and inflammatory disorders, live the life they love”, says Philippe Sollie. In total Flen Health secured over €2.5 million non-dilutive funding over the past two & half years and has over €8 million non-dilutive funding pending this year, not only in Europe but also in the US. “With a new promising project, that we would like to realise in Luxembourg, aimed at integrative treatment development, we will significantly change how wounds are treated. These disruptive technologies are being developed in our in-house facilities as well as in collaboration with research centres in Europe and the USA. But our mission is not only to develop innovative technologies but also to support in building a more inclusive community, support social and economic growth”, explains Gilles Brackman. About Flen Health Flen Health believes biotech innovation can help to build a securer life for all of us. With its product portfolio, Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin diseases in a responsible way by providing added value for patients, healthcare professionals and health authorities. Learn more about Flen Health
"After the crisis we will find out that COVID-19 has changed our lives substantially", Philippe Sollie, CEO, Flen Health. Join us for a first-hand look at the impact of the global shutdown following the corona virus outbreak. "We should continue to focus on building international ties & to find solutions in this new reality", Philippe Sollie. EACC New York creates together with its members a video series of first-hand accounts of the Pandemic’s impact, both personally & professionally. Philippe Sollie answered the following questions to EACCNY: 1) What are some challenges you, personally and your organization have faced? 2) What are some of the most surprising (positive, innovative) responses/changes you have witnessed? 3) How will this experience change us going forward, as a society and in terms of how we do business? EACCNY has its finger on the pulse of how this worldwide pandemic is affecting companies and organisations on both sides of the Atlantic. EACC is where Americans & Europeans connect to do business. Please find more video series of first-hand accounts of the Pandemic’s impact here.
How Flamigel® helps the healthcare sector to keep hands healthy! Flen Health, a Belgian wound and skin care company known for Flamigel®, donates more than 300,000 EUR in the form of free of charge Flamigel® tubes to all healthcare professionals in Belgian and Luxembourgish hospitals. For Flen Health this is the time to show solidarity and to take action! Currently, we all wash our hands sufficiently to fight against the COVID-19 virus. Unfortunately, this increases the risk of dehydration and irritation of the hands because the natural layer of oil disappears. This counts for all of us, healthcare providers and doctors but also for workers in various sectors, parents, in short, everyone. Flamigel® helps to moisturise and to heal our hands. As a company, however, Flen Health wants to set a positive example! "People in the healthcare sector are working day and night to contain the impact of the coronavirus. Within our company we were looking for a way to help them, so we came up with the idea of distributing our product Flamigel® for free. Flamigel® has been developed for the treatment of superficial burns and abrasions, because it is very suitable for healing damaged skin. The hands of most people in the care sector are starting to get red, sore or damaged as a result of frequent hand washing. This makes further work and handwashing not only difficult, but also painful. The vulnerability increases but people want to keep on working. Pain in the hands, in addition to fatigue, reduces motivation," says Philippe Sollie, CEO Flen Health. "We all should stick together and help! I would therefore also like to call on my colleagues from the pharmaceutical sector to find a way to support the healthcare sector. After all, together we can contain this terrible virus. All over the world we now need each other's support", explains Philippe Sollie further. How does it work in practice? Any hospital in Belgium and Luxembourg can contact us by filling in the form and we will contact your hospital pharmacy. About Flamigel® Flamigel® is for all kinds of superficial wounds. It is an innovative gel that contributes to faster wound healing and reduces scar formation. The hydroactive-colloid gel works to the effective principle of moist wound healing. Flamigel® heals wounds up to 40 % faster, cools and soothes the skin and creates a protective skin layer. About Flen Health Flen Health believes biotech innovations can help to build a securer life for all of us. With its product portfolio Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin and wound diseases in a responsible way, by providing added value for patients, healthcare professionals and health authorities. Starting in 2000 as a one-man Belgian operation, the company has grown to an international family enterprise with market-leading positions and over 100 motivated employees. Flen Health is represented by two headquarters with innovation centres in Belgium and Luxembourg. Further affiliates are located in the Netherlands, Germany, UK, US and UAE. This year the company celebrates its 20th anniversary. Note for the editor / not for publication: For further information please contact Kristine Vanlinthout via telephone +32 3 450 84 99 or via mail Kristine.Vanlinthout@flenhealth.com
"Being told that one has Cancer is not much fun, and when I was diagnosed nearly 18 months ago it was inevitably a shock. This was compounded by the certainty of an operation (double mastectomy), possibility of chemotherapy and almost certainty of Radiotherapy." The Chemo I escaped, the operation went well, but it was the anticipation of the Radiotherapy which, for me, presented the worst fears. It was not a fear of ‘nuclear medicine’, it was the side-effects: I was almost promised these...blistering, weeping skin, bright red and extremely itchy patches around the treated areas. The fact that these things would blow up AFTER the treatment was ended made it seem worse, treatment that in itself was fairly grim - having to lie unnaturally still for what seemed like ages: having one’s body heaved around to ‘position’ it and not being allowed to help - incredibly undignified. It was just before I started Radiotherapy, however, that I was introduced to someone who had travelled an identical path to mine, and she swore by Flamigel® RT, a cream that had been given to her by the hospital where she had undertaken her cancer treatment. It was prescription only, but when I asked Guy’s for one, they denied all knowledge of it, and continued to ‘sell’ E45. Eventually our GP, himself a ‘skin man’, agreed that Flamigel® was the route to take. About four days into my Radiotherapy I switched from E45 to Flamigel® RT. And I have not looked back... I have had NONE of the promised nasties, no weeping skin, no blistering effects like sunburn. Yes, three weeks after I finished treatment two angry red patches appeared around my collar bone but they only itch a tiny bit, easily soothed by a quick application of Flamigel®, and I expect them to go away soon. And the cream doesn’t smell, it leaves no stain on clothing and is very quickly absorbed. Most importantly, of course, it WORKS and I had none of the miseries that I had anticipated. Cancer is a horrible and frightening thing to have, but it makes a huge difference to have something which so effectively eases the many irritants which its treatment seem to generate. I sincerely hope that Flamigel® RT will soon be widely and easily available to ALL those unfortunate enough to have to undergo the rigours of Radiotherapy.” Speaking about terrifying memories takes a lot of courage and strength therefore we very much appreciate that Sarah told us her story. Thank you for your trust Sarah!
20 years of turning research into effective skin and wound healing solutions Brussels, January 2020: Flen Health proudly announces its 20-year anniversary. Starting in 2000 as a one-man Belgian operation, the company has grown to an international family enterprise with market-leading positions and over 100 motivated employees. “By listening to patients, working hand in hand with healthcare professionals and continuously investing our efforts in research and development the company has grown and established itself as an innovative provider of solutions to the health care market”, explains Philippe Sollie, founder and CEO, Flen Health. Today, the company is represented by two headquarters with innovation centres in Belgium and Luxembourg. Further affiliates are located in the Netherlands, Germany, UK, US and UAE. The company’s product portfolio is constantly growing and follows a biotechnological approach to protect what is good in the wound and eliminate what is bad, thus providing what is needed for a wound to heal. All efforts are based on the objective to turn research into effective, safe plus easy-to-use skin and wound healing solutions. In order to follow this objective Flen Health continuously translates expertise from patients and healthcare professionals into new technologies for a healthier skin. “Our slogan ‘creating with You in mind’ is founded on my experience and is at the heart of our daily operations. Only if we work closely with the ones using our products, are we able to identify unmet needs and provide the right solutions”, believes Philippe Sollie. Prior to 2000, Philippe worked as a pharmacist in Belgium. Following an accident where his friend’s little daughter suffered severe burns and a subsequent allergic reaction to existing treatment products, he wanted to help. Together with the Head of the Antwerp Burns Centre, Philippe developed Flamigel® which continues to prove its wound healing effectiveness. This positive experience led to the foundation of Flen Health and has since generated many more patient success stories. It is these patient successes that give us cause to celebrate and the motivation to continue to create innovation with You in mind. Flen Health has been labelled EU innovative company and has secured several research grants. “The success we have had in obtaining non-dilutive funding for research, our ability to construct strong, sustainable partnerships and agreements with academic as well as non-academic partners both inside and outside of Europe in the past 20 years, demonstrate that we are respected for our expertise and for our vision for the future”, states Gilles Brackman, Vice President R&D, Flen Health. Thank You for Your trust in us, today and tomorrow. About Flen Health Flen Health believes biotech innovations can help to build a securer life for all of us. With its product portfolio Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin diseases in a responsible way, by providing added value for patients, healthcare professionals and health authorities. Learn more about Flen Health
What a wonderful surprise! Two Consumer Healthcare Communication Awards (CHCA) have been awarded to Flamigel® in the categories Best User Friendly Campaign and Most Efficient Campaign. Thank you to all loyal fans, consumers and pharmacists who voted for Flamigel®! BACHI initiates the CHCA and the award ceremony took place on January 16th in Brussels. We are so proud and we will continue to give our best in 2020!